Descripción general
-
La craneosinostosis se define como la fusión prematura de una o más suturas craneales, que a menudo resulta en una forma anormal de la cabeza. Es una anomalía craneofacial del desarrollo resultante de un defecto primario de osificación (craneosinostosis primaria) o, más comúnmente, de una falla del crecimiento cerebral (craneosinostosis secundaria). Además, la craneosinostosis puede ser simple cuando solo una sutura se fusiona prematuramente o compleja / compuesta cuando hay una fusión prematura de múltiples suturas. Las craneosinostosis complejas suelen estar asociadas con otras deformidades corporales. El principal riesgo de morbilidad es la presión intracraneal elevada y el consiguiente daño cerebral. Cuando no se trata, la craneosinostosis puede causar complicaciones graves como retraso en el desarrollo, anomalías faciales, disfunción sensorial, respiratoria y neurológica, anomalías oculares y alteraciones psicosociales. En aproximadamente el 85% de los casos, esta enfermedad es aislada y no sindrómica. La craneosinostosis sindrómica suele presentarse con complicaciones multiorgánicas.
-
El panel de precisión de craneosinostosis de Igenomix se puede utilizar para realizar un diagnóstico directo y preciso que, en última instancia, conduce a un mejor manejo y pronóstico de la enfermedad. Proporciona un análisis completo de los genes implicados en esta enfermedad utilizando secuenciación de próxima generación (NGS) para comprender completamente el espectro de genes relevantes implicados.
Utilidad clínica
La utilidad clínica de este panel es:
-
La confirmación genética y molecular para un diagnóstico clínico preciso de un paciente sintomático.
-
Inicio temprano del tratamiento en forma de procedimientos quirúrgicos para aliviar las suturas fusionadas, avance de la zona media de la cara, fase limitada del tratamiento de ortodoncia y tratamiento combinado de ortodoncia / cirugía ortognática. Monitorear y prevenir complicaciones de la presión intracraneal elevada.
-
Evaluación de riesgos y asesoramiento genético de familiares asintomáticos según modalidad hereditaria.
-
Mejora de la delimitación de la correlación genotipo-fenotipo.
Genes y enfermedades
GENE |
OMIM DISEASES |
INHERITANCE* |
% GENE COVERAGE (20X) |
HGMD** |
ADAMTS3 |
Hennekam |
AR |
99.97 |
4 of 4 |
AHDC1 |
Xia-Gibbs Syndrome, |
AD |
99.87 |
41 of 43 |
AKT1 |
Proteus Syndrome, |
AD |
100 |
6 of 6 |
ALPL |
Hypophosphatasia |
AD,AR |
100 |
320 of 321 |
ALX3 |
Frontonasal |
AR |
89.31 |
8 of 8 |
ALX4 |
Craniosynostosis, |
AD,AR |
99.94 |
25 of 25 |
APC2 |
Complex Cortical Dysplasia, |
AR |
94.97 |
11 of 11 |
ARVCF |
22q11.2 Deletion |
– |
99.95 |
2 of 2 |
ASXL1 |
Bohring-Opitz Syndrome, |
AD |
99.96 |
41 of 41 |
ATR |
Cutaneous Telangiectasia |
AD,AR |
99.98 |
39 of 40 |
ATRIP |
Seckel Syndrome |
– |
99.89 |
2 of 2 |
B3GAT3 |
Multiple Joint Dislocations, |
AR |
99.86 |
15 of 15 |
B3GLCT |
Peters Plus |
AR |
99.96 |
– |
B4GALT7 |
Ehlers-Danlos Syndrome, |
AR |
99.92 |
11 of 11 |
BMP4 |
Syndromic Microphthalmia, |
AD,MU,P |
100 |
38 of 42 |
BPNT2 |
Chondrodysplasia |
AR |
97.04 |
4 of 4 |
CCBE1 |
Hennekam |
AR |
100 |
16 of 16 |
CCNQ |
Toe Syndactyly, |
X,XD,G |
99.59 |
– |
CD96 |
C Syndrome |
AD |
100 |
4 of 4 |
CDC45 |
Meier-Gorlin Syndrome, |
AR |
99.99 |
19 of 19 |
CDC6 |
Meier-Gorlin Syndrome, |
AR |
100 |
2 of 2 |
CDH11 |
Elsahy-Waters Syndrome, |
AR |
99.95 |
10 of 10 |
CDT1 |
Meier-Gorlin Syndrome, |
AR |
97.43 |
12 of 12 |
CENPE |
Primary Microcephaly, |
AR |
95.69 |
5 of 5 |
CENPJ |
Autosomal Recessive |
AR |
99.97 |
13 of 13 |
CEP120 |
Joubert Syndrome, Short-Rib |
AR |
99.8 |
9 of 9 |
CEP152 |
Autosomal Recessive |
AR |
97.73 |
21 of 24 |
CHST14 |
Musculocontractural |
AR |
97.7 |
21 of 22 |
CHST3 |
Multiple Joint Dislocations, |
AR |
99.97 |
38 of 38 |
CLCN7 |
Osteopetrosis, Albers- |
AD,AR |
99.85 |
109 of 111 |
COLEC10 |
3mc Syndrome |
AR |
99.95 |
3 of 3 |
COLEC11 |
Carnevale Syndrome, |
AR |
100 |
11 of 11 |
COMT |
22q11.2 Deletion |
AD |
99.98 |
5 of 5 |
CTCF |
Intellectual Disability- |
AD |
96.6 |
39 of 41 |
CWC27 |
Retinitis Pigmentosa |
AR |
99.77 |
8 of 8 |
CYP26B1 |
Craniosynostosis With |
AR |
100 |
12 of 12 |
DMP1 |
Hypophosphatemic |
AR |
99.89 |
11 of 11 |
DONSON |
Microcephaly-Micromelia |
AR |
98.14 |
26 of 27 |
DPF2 |
Coffin-Siris |
AD |
99.99 |
10 of 10 |
DPH1 |
Developmental Delay With |
AR |
100 |
8 of 8 |
DSE |
Musculocontractural |
AR |
99.94 |
3 of 3 |
EDNRB |
Abcd Syndrome, |
AD,AR |
99.55 |
70 of 72 |
EFNB1 |
Craniofrontonasal |
X,XD,G |
100 |
– |
ENPP1 |
Cole Disease, |
AD,AR,MU,P |
96.59 |
73 of 75 |
ERCC2 |
Cerebrooculofacioskeletal |
AR |
100 |
102 of 102 |
ERCC3 |
Trichothiodystrophy, |
AR |
99.98 |
24 of 24 |
ERF |
Chitayat Syndrome, |
AD |
99.73 |
31 of 31 |
ESCO2 |
Roberts Syndrome, |
AR |
99.69 |
32 of 32 |
ETS2 |
Down Syndrome |
|
99.99 |
1 of 2 |
EXTL3 |
Immunoskeletal Dysplasia |
AR |
99.99 |
10 of 10 |
FAT4 |
Hennekam |
AR |
99.8 |
41 of 41 |
FBN1 |
Acromicric Dysplasia, |
AD |
100 |
2836 of 2845 |
FGF9 |
Multiple Synostoses |
AD |
100 |
2 of 2 |
FGFR1 |
Encephalocraniocutaneous |
AD |
100 |
279 of 280 |
FGFR2 |
Antley-Bixler Syndrome |
AD |
98 |
140 of 143 |
FGFR3 |
Achondroplasia With |
AD,AR |
99.89 |
77 of 78 |
FLNA |
Fg Syndrome, |
X,XR,XD,G |
100 |
– |
FLNB |
Atelosteogenesis, Boomerang |
AD,AR |
100 |
124 of 124 |
FREM1 |
Manitoba Oculotrichoanal |
AD,AR |
97.32 |
27 of 30 |
GDF5 |
Acromesomelic Dysplasia, |
AD,AR |
99.48 |
48 of 51 |
GLI3 |
Greig Cephalopolysyndactyly |
AD,AR |
100 |
231 of 231 |
GLIS3 |
Diabetes Mellitus, |
AR |
99.83 |
21 of 21 |
GMNN |
Meier-Gorlin Syndrome, |
AD |
99.72 |
3 of 3 |
GNPTAB |
Mucolipidosis |
AR |
100 |
279 of 280 |
GP1BB |
22q11.2 Deletion |
AR |
74.08 |
26 of 50 |
GPC6 |
Autosomal Recessive |
AR |
99.92 |
3 of 3 |
GTF2E2 |
Nonphotosensitive |
AR |
99.98 |
2 of 2 |
GTF2H5 |
Photosensitive |
AR |
100 |
8 of 8 |
HIRA |
22q11.2 Deletion |
– |
99.99 |
5 of 5 |
HNRNPK |
Au-Kline Syndrome; |
AD |
99.88 |
16 of 17 |
HUWE1 |
X-linked Intellectual |
X,G |
99.41 |
– |
IFT122 |
Cranioectodermal |
AR |
99.83 |
22 of 22 |
IFT140 |
Short-Rib Thoracic |
AR |
99.97 |
81 of 81 |
IFT43 |
Cranioectodermal |
AR |
100 |
6 of 6 |
IFT52 |
Short-Rib Thoracic |
AR |
99.8 |
8 of 8 |
IHH |
Acrocapitofemoral |
AD,AR |
99.39 |
28 of 29 |
IL11RA |
Craniosynostosis |
AR |
100 |
22 of 22 |
IL6ST |
Hyper-IgE Recurrent |
AR |
99.34 |
2 of 2 |
IRX5 |
Hamamy |
AR |
97.1 |
5 of 5 |
JMJD1C |
22q11.2 Deletion |
|
99.09 |
27 of 27 |
KAT6A |
Arboleda-Tham |
AD |
99.89 |
66 of 68 |
KPTN |
Macrocephaly- |
AR |
100 |
5 of 5 |
KRAS |
Aplasia Cutis |
AD |
100 |
38 of 38 |
LEMD3 |
Buschke-Ollendorff |
AD |
99.06 |
30 of 33 |
LIG4 |
Lig4 Syndrome, |
AR |
99.48 |
46 of 46 |
LRP5 |
Endosteal |
AD,AR |
98.12 |
265 of 269 |
MAF |
Ayme-gripp Syndrome, |
AD |
75.14 |
23 of 23 |
MAN2B1 |
Alpha-Mannosidosis |
AR |
100 |
149 of 149 |
MAP3K7 |
Cardiospondylocarpofacial |
AD |
99.96 |
13 of 13 |
MASP1 |
3mc Syndrome |
AR |
100 |
29 of 30 |
MED12 |
Lujan-Fryns Syndrome, |
X,XR,G |
100 |
– |
MEGF8 |
Carpenter |
AR |
98.97 |
22 of 22 |
MIR140 |
Spondyloepiphyseal |
AD |
– |
– |
MPLKIP |
Nonphotosensitive |
AR |
100 |
13 of 13 |
MSX2 |
Craniosynostosis, |
AD |
99.98 |
15 of 15 |
MYH3 |
Arthrogryposis, |
AD,AR |
100 |
46 of 47 |
NFIX |
Marshall-Smith |
AD |
94.42 |
75 of 81 |
NOG |
Brachydactyly, Multiple |
AD |
99.89 |
61 of 62 |
NSD1 |
Sotos Syndrome, 5q35 |
AD |
99.8 |
451 of 459 |
NSUN2 |
Autosomal Recessive |
AR |
99.99 |
8 of 8 |
ORC1 |
Ear, Patella, Short |
AR |
100 |
12 of 12 |
ORC4 |
Meier-Gorlin Syndrome, |
AR |
100 |
4 of 4 |
ORC6 |
Meier-Gorlin Syndrome, |
AR |
100 |
6 of 6 |
P4HB |
Cole-Carpenter |
AD |
94.97 |
13 of 13 |
PAX3 |
Craniofacial-Deafness- |
AD,AR |
99.98 |
157 of 157 |
PCNT |
Microcephalic |
AR |
99.92 |
103 of 105 |
PHEX |
X-linked |
X,XD,G |
99.42 |
– |
PIGT |
Multiple Congenital |
AD,AR |
100 |
15 of 15 |
PLK4 |
Microcephaly And |
AR |
99.74 |
10 of 10 |
POLA1 |
Van Esch-O’driscoll |
X,XR,G |
99.26 |
– |
POR |
Antley-Bixler Syndrome |
AD,AR |
99.98 |
67 of 68 |
PPP1CB |
Noonan Syndrome- |
AD |
99.87 |
12 of 12 |
PPP3CA |
Arthrogryposis, Cleft |
AD |
99.98 |
16 of 16 |
PSAT1 |
Neu-Laxova Syndrome, |
AR |
99.95 |
9 of 9 |
PTEN |
Macrocephaly/Autism |
AD |
99.97 |
609 of 629 |
RAB23 |
Carpenter Syndrome |
AR |
100 |
15 of 15 |
RAC3 |
Neurodevelopmental |
AD |
94.13 |
5 of 5 |
RBBP8 |
Jawad Syndrome, |
AR |
96.02 |
6 of 6 |
RECQL4 |
Baller-Gerold |
AR |
96.72 |
134 of 135 |
RNF113A |
Nonphotosensitive |
X,XD,G |
99.7 |
– |
RREB1 |
22q11.2 Deletion |
|
99.92 |
8 of 8 |
RSPRY1 |
Spondyloepimetaphyseal |
AR |
99.98 |
4 of 4 |
RTTN |
Microcephaly, |
AR |
99.94 |
28 of 29 |
RUNX2 |
Cleidocranial Dysplasia, |
AD |
73.67 |
189 of 190 |
SCARF2 |
Van Den Ende-Gupta |
AR |
93.06 |
13 of 13 |
SEC24C |
22q11.2 Deletion |
|
99.98 |
– |
SEC24D |
Cole-Carpenter |
AR |
99.97 |
14 of 14 |
SETD2 |
Luscan-Lumish |
AD |
99.83 |
19 of 19 |
SKI |
Shprintzen-Goldberg |
AD |
99.66 |
39 of 39 |
SLC12A6 |
Corpus Callosum |
AR |
100 |
21 of 21 |
SLC25A24 |
Fontaine Progeroid |
AD |
99.59 |
2 of 2 |
SLC2A10 |
Arterial Tortuosity |
AR |
100 |
35 of 35 |
SLC35A2 |
Congenital Disorder |
X,XD,G |
99.97 |
– |
SLC39A8 |
Congenital Disorder |
AR |
99.89 |
7 of 7 |
SMAD3 |
Loeys-Dietz Syndrome, |
AD |
100 |
128 of 128 |
SMAD6 |
Craniosynostosis |
AD |
80.88 |
64 of 74 |
SMO |
Craniofacial Malformations |
AR |
94.03 |
10 of 10 |
SNX10 |
Autosomal Recessive |
AR |
100 |
14 of 14 |
SON |
Zttk Syndrome, Brain |
AD |
99.27 |
30 of 32 |
SOX10 |
Peripheral Demyelinating |
AD |
99.74 |
139 of 147 |
SPECC1L |
Facial Clefting, |
AD |
99.66 |
14 of 14 |
STAT3 |
Hyper-IgE Recurrent |
AD |
100 |
171 of 171 |
TANC2 |
Intellectual Developmental |
AD |
97.81 |
21 of 21 |
TARS1 |
Nonphotosensitive |
AR |
99.94 |
– |
TBC1D24 |
Doors Syndrome, Rolandic |
AD,AR |
100 |
80 of 80 |
TBX1 |
DiGeorge Syndrome, |
AD,AR |
88.7 |
35 of 42 |
TCF12 |
Craniosynostosis, |
AD |
99.98 |
73 of 76 |
TCIRG1 |
Osteopetrosis, |
AR |
100 |
140 of 146 |
TCOF1 |
Treacher Collins- |
AD |
100 |
326 of 327 |
TGFB2 |
Loeys-Dietz |
AD |
99.9 |
41 of 44 |
TGFB3 |
Loeys-Dietz |
AD |
100 |
34 of 35 |
TGFBR1 |
Loeys-Dietz |
AD |
94 |
96 of 100 |
TGFBR2 |
Loeys-Dietz |
AD |
99.9 |
165 of 166 |
TLK2 |
Autosomal Dominant |
AD |
96.98 |
39 of 39 |
TMCO1 |
Cerebrofaciothoracic |
AR |
88 |
5 of 5 |
TNFSF11 |
Autosomal Recessive |
AR |
99.84 |
4 of 4 |
TRAIP |
Seckel Syndrome |
AR |
100 |
2 of 2 |
TWIST1 |
Craniosynostosis, |
AD |
74.06 |
133 of 161 |
TWIST2 |
Ablepharon-Mac |
AD,AR |
99.82 |
9 of 9 |
UFD1 |
22q11.2 Deletion |
– |
99.98 |
– |
WDR19 |
Cranioectodermal |
AR |
99.96 |
47 of 49 |
WDR35 |
Cranioectodermal |
AR |
100 |
31 of 33 |
YY1 |
Gabriele-de Vries |
AD |
99.89 |
13 of 13 |
ZEB2 |
Mowat-Wilson |
AD |
98.95 |
253 of 254 |
ZIC1 |
Craniosynostosis, |
AD |
100 |
7 of 7 |
* Herencia: AD: Autosómico Dominante; AR: autosómico recesivo; X: ligado a X; XLR: recesivo vinculado a X; Mi: mitocondrial; Mu: multifactorial; G: herencia gonosomal; D: herencia digénica
** HGMD: número de mutaciones clínicamente relevantes según HGMD
Referencias
Delahaye S, Bernard JP, Rénier D, Ville Y. Prenatal ultrasound diagnosis of fetal craniosynostosis. Ultrasound Obstet Gynecol. 2003 Apr;21(4):347-53. doi: 10.1002/uog.91. PMID: 12704742
Kajdic, N., Spazzapan, P., & Velnar, T. (2018). Craniosynostosis – Recognition, clinical characteristics, and treatment. Bosnian journal of basic medical sciences, 18(2), 110–116. https://doi.org/10.17305/bjbms.2017.2083
Wilkie, A., Johnson, D., & Wall, S. A. (2017). Clinical genetics of craniosynostosis. Current opinion in pediatrics, 29(6), 622–628. https://doi.org/10.1097/MOP.0000000000000542
Kutkowska-Kaźmierczak, A., Gos, M., & Obersztyn, E. (2018). Craniosynostosis as a clinical and diagnostic problem: molecular pathology and genetic counseling. Journal of applied genetics, 59(2), 133–147. https://doi.org/10.1007/s13353-017-0423-4
Wang, J. C., Nagy, L., & Demke, J. C. (2016). Syndromic Craniosynostosis. Facial plastic surgery clinics of North America, 24(4), 531–543. https://doi.org/10.1016/j.fsc.2016.06.008
Azoulay-Avinoam, S., Bruun, R., MacLaine, J., Allareddy, V., Resnick, C. M., & Padwa, B. L. (2020). An Overview of Craniosynostosis Craniofacial Syndromes for Combined Orthodontic and Surgical Management. Oral and maxillofacial surgery clinics of North America, 32(2), 233–247. https://doi.org/10.1016/j.coms.2020.01.004
Jabs, E. (2008). Toward understanding the pathogenesis of craniosynostosis through clinical and molecular correlates. Clinical Genetics, 53(2), 79-86. doi: 10.1111/j.1399-0004.1998.tb02648.x
Kimonis, V., Gold, J., Hoffman, T., Panchal, J., & Boyadjiev, S. (2007). Genetics of Craniosynostosis. Seminars In Pediatric Neurology, 14(3), 150-161. doi: 10.1016/j.spen.2007.08.008
Lattanzi, W., Barba, M., Di Pietro, L., & Boyadjiev, S. A. (2017). Genetic advances in craniosynostosis. American journal of medical genetics. Part A, 173(5), 1406–1429. https://doi.org/10.1002/ajmg.a.38159